Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)

Chelsea C. Pinnix; Bouthaina S. Dabaja; Sarah A. Milgrom; Grace L. Smith; Zeinab Abou; Loretta Nastoupil; Jorge Romaguera; Francesco Turturro; Nathan Fowler; Luis Fayad; Jason Westin; Sattva Neelapu; Michelle A. Fanale; Maria A. Rodriguez; Frederick Hagemeister; Hun Ju Lee; Yasuhiro Oki; Michael Wang; Felipe Samaniego; Linda Chi; Bita Esmaeli

doi:10.1002/hed.25149

Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)

Chelsea C. Pinnix, Bouthaina S. Dabaja, Sarah A. Milgrom, Grace L. Smith, Zeinab Abou, Loretta Nastoupil, Jorge Romaguera, Francesco Turturro, Nathan Fowler, Luis Fayad, Jason Westin, Sattva Neelapu, Michelle A. Fanale, Maria A. Rodriguez, Frederick Hagemeister, Hun Ju Lee, Yasuhiro Oki, Michael Wang, Felipe Samaniego, Linda ChiBita Esmaeli

Houston Methodist

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

The authors have brought to our attention that an incorrect panel B was supplied for Figure. A corrected Figure, panels A-D, appears below. The authors apologize for their error. (Figure presented.) Complete response to ultra–low-dose orbital radiotherapy (RT) for mantle cell lymphoma (MCL) achieved 10 months after completion of RT. (A) A 70-year-old woman with stage IV MCL had a dominant enhancing left lacrimal gland mass measuring 2.631.5 cm on axial postcontrast CT imaging. (B) She was treated with 4 Gy in 2 fractions with 16-MeV electrons. (C) She had a partial response to RT at 4 months after completion of RT. (D) She had a complete response to RT at 10.5 months after completion of RT without any interval treatment [Color figure can be viewed at wileyonlinelibrary.com].

Original language	English (US)
Pages (from-to)	1335
Number of pages	1
Journal	Head and Neck
Volume	40
Issue number	6
DOIs	https://doi.org/10.1002/hed.25149
State	Published - Jun 2018

ASJC Scopus subject areas

Otorhinolaryngology

Access to Document

10.1002/hed.25149

Cite this

Pinnix, C. C., Dabaja, B. S., Milgrom, S. A., Smith, G. L., Abou, Z., Nastoupil, L., Romaguera, J., Turturro, F., Fowler, N., Fayad, L., Westin, J., Neelapu, S., Fanale, M. A., Rodriguez, M. A., Hagemeister, F., Ju Lee, H., Oki, Y., Wang, M., Samaniego, F., ... Esmaeli, B. (2018). Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717). Head and Neck, 40(6), 1335. https://doi.org/10.1002/hed.25149

Pinnix, CC, Dabaja, BS, Milgrom, SA, Smith, GL, Abou, Z, Nastoupil, L, Romaguera, J, Turturro, F, Fowler, N, Fayad, L, Westin, J, Neelapu, S, Fanale, MA, Rodriguez, MA, Hagemeister, F, Ju Lee, H, Oki, Y, Wang, M, Samaniego, F, Chi, L & Esmaeli, B 2018, 'Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)', Head and Neck, vol. 40, no. 6, pp. 1335. https://doi.org/10.1002/hed.25149

@article{03d7cb42b4474d68a6587093d7727473,

title = "Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)",

abstract = "The authors have brought to our attention that an incorrect panel B was supplied for Figure. A corrected Figure, panels A-D, appears below. The authors apologize for their error. (Figure presented.) Complete response to ultra–low-dose orbital radiotherapy (RT) for mantle cell lymphoma (MCL) achieved 10 months after completion of RT. (A) A 70-year-old woman with stage IV MCL had a dominant enhancing left lacrimal gland mass measuring 2.631.5 cm on axial postcontrast CT imaging. (B) She was treated with 4 Gy in 2 fractions with 16-MeV electrons. (C) She had a partial response to RT at 4 months after completion of RT. (D) She had a complete response to RT at 10.5 months after completion of RT without any interval treatment [Color figure can be viewed at wileyonlinelibrary.com].",

author = "Pinnix, \{Chelsea C.\} and Dabaja, \{Bouthaina S.\} and Milgrom, \{Sarah A.\} and Smith, \{Grace L.\} and Zeinab Abou and Loretta Nastoupil and Jorge Romaguera and Francesco Turturro and Nathan Fowler and Luis Fayad and Jason Westin and Sattva Neelapu and Fanale, \{Michelle A.\} and Rodriguez, \{Maria A.\} and Frederick Hagemeister and \{Ju Lee\}, Hun and Yasuhiro Oki and Michael Wang and Felipe Samaniego and Linda Chi and Bita Esmaeli",

note = "Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",

year = "2018",

month = jun,

doi = "10.1002/hed.25149",

language = "English (US)",

volume = "40",

pages = "1335",

journal = "Head and Neck",

issn = "1043-3074",

publisher = "John Wiley \& Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Erratum to

T2 - Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)

AU - Pinnix, Chelsea C.

AU - Dabaja, Bouthaina S.

AU - Milgrom, Sarah A.

AU - Smith, Grace L.

AU - Abou, Zeinab

AU - Nastoupil, Loretta

AU - Romaguera, Jorge

AU - Turturro, Francesco

AU - Fowler, Nathan

AU - Fayad, Luis

AU - Westin, Jason

AU - Neelapu, Sattva

AU - Fanale, Michelle A.

AU - Rodriguez, Maria A.

AU - Hagemeister, Frederick

AU - Ju Lee, Hun

AU - Oki, Yasuhiro

AU - Wang, Michael

AU - Samaniego, Felipe

AU - Chi, Linda

AU - Esmaeli, Bita

PY - 2018/6

Y1 - 2018/6

N2 - The authors have brought to our attention that an incorrect panel B was supplied for Figure. A corrected Figure, panels A-D, appears below. The authors apologize for their error. (Figure presented.) Complete response to ultra–low-dose orbital radiotherapy (RT) for mantle cell lymphoma (MCL) achieved 10 months after completion of RT. (A) A 70-year-old woman with stage IV MCL had a dominant enhancing left lacrimal gland mass measuring 2.631.5 cm on axial postcontrast CT imaging. (B) She was treated with 4 Gy in 2 fractions with 16-MeV electrons. (C) She had a partial response to RT at 4 months after completion of RT. (D) She had a complete response to RT at 10.5 months after completion of RT without any interval treatment [Color figure can be viewed at wileyonlinelibrary.com].

AB - The authors have brought to our attention that an incorrect panel B was supplied for Figure. A corrected Figure, panels A-D, appears below. The authors apologize for their error. (Figure presented.) Complete response to ultra–low-dose orbital radiotherapy (RT) for mantle cell lymphoma (MCL) achieved 10 months after completion of RT. (A) A 70-year-old woman with stage IV MCL had a dominant enhancing left lacrimal gland mass measuring 2.631.5 cm on axial postcontrast CT imaging. (B) She was treated with 4 Gy in 2 fractions with 16-MeV electrons. (C) She had a partial response to RT at 4 months after completion of RT. (D) She had a complete response to RT at 10.5 months after completion of RT without any interval treatment [Color figure can be viewed at wileyonlinelibrary.com].

UR - https://www.scopus.com/pages/publications/85042187783

UR - https://www.scopus.com/inward/citedby.url?scp=85042187783&partnerID=8YFLogxK

U2 - 10.1002/hed.25149

DO - 10.1002/hed.25149

M3 - Comment/debate

C2 - 29851218

AN - SCOPUS:85042187783

SN - 1043-3074

VL - 40

SP - 1335

JO - Head and Neck

JF - Head and Neck

IS - 6

ER -

Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this